
CHROMOSOME TORSIONS IN CYTOGENETIC
PREPARATIONS OF BONE MARROW –
ARTIFACTS OR LEUKEMIA-SPECIFIC?
Glaser M1, Karst C1, Gross M1, Hasmik M2, Liehr T1,* *Corresponding Author: Dr. Thomas Liehr, Institut für Humangenetik und Anthroplogie, Postfach, D-07740 Jena, Germany; Tel.: +49-3641-935533; Fax: +49-3641-935582; Email: i8lith@mti.uni-jena.de page: 27
|
INTRODUCTION
An integral part of the diagnosis of human leukemia is the cytogenetic analysis of bone marrow aspirate for specific acquired chromosomal abnormalities. Recurrent chromosomal aberrations result from events at the molecular level and the affected chromosomal regions may contain genes that promote or cause the disease. Routine cytogenetics has identified many important karyotypic changes that gave hints on the localization of oncogenes or tumor suppressor genes [1,2]. The introduction, in the last decade, of molecular cytogenetics has facilitated routine tumor cytogenetic analysis.
After standard chromosome banding (i.e., GTG-banding) in about 30 to 50% of patients with acute myelogeneous leukemia (AML) no cytogenetic changes were detectable in the bone marrow cells [3]. As GTG- banding cannot detect all possible chromosomal changes [4,5], a search for additional cryptic chromosomal aberrations was carried out in a series of AML cases. These specimens, which were, according to GTG-banding results, cytogenetically normal, were studied using the multitude multicolor banding (mMCB) technique [5]. During these studies, we came across an anomaly we called “chromosome torsion”, i.e., the chromatids of the p- and the q-arm were located side-by-side rather than in the usual tandem alignment. Such torsions were previously seen during leukemia banding cytogenetic diagnostics (Dr. E. Gebhart, Erlangen, Germany, personal communication, 2004), however, this has not thus far been studied in detail.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|